Banque Transatlantique SA raised its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 247.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,396 shares of the company's stock after purchasing an additional 29,491 shares during the quarter. Banque Transatlantique SA's holdings in Procter & Gamble were worth $6,519,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nuveen LLC purchased a new position in shares of Procter & Gamble during the first quarter worth approximately $1,954,941,000. GAMMA Investing LLC increased its position in shares of Procter & Gamble by 20,758.5% during the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. increased its holdings in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Procter & Gamble by 15.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after buying an additional 2,224,912 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on PG shares. BNP Paribas restated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Barclays set a $164.00 target price on shares of Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Evercore ISI reissued an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Wells Fargo & Company decreased their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $175.12.
View Our Latest Analysis on PG
Procter & Gamble Stock Up 0.6%
Shares of NYSE:PG traded up $0.89 during trading hours on Friday, reaching $160.08. The stock had a trading volume of 6,435,480 shares, compared to its average volume of 6,113,774. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The firm's 50 day moving average is $156.41 and its 200-day moving average is $162.28. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a market capitalization of $374.65 billion, a price-to-earnings ratio of 24.59, a P/E/G ratio of 4.20 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.6%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 64.82%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Susan Street Whaley sold 1,000 shares of the business's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the completion of the sale, the insider directly owned 28,436 shares in the company, valued at approximately $4,459,902.24. The trade was a 3.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 8,596 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the completion of the sale, the chief executive officer owned 64,991 shares of the company's stock, valued at approximately $10,221,134.57. The trade was a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 120,181 shares of company stock valued at $18,918,012. Corporate insiders own 0.18% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report